Metaphore Biotechnologies

Metaphore Biotechnologies is a next-generation antibody therapeutics company founded by Flagship Pioneering, a U.S.-based venture capital firm. Metaphore's proprietary AI drug discovery platform, MIMIC™, differs from traditional structure-dependent approaches as it is designed based on biofunctional antibodies. The platform integrates artificial intelligence analysis of large-scale functional data obtained from living cells, combined with dynamic protein interaction information. This unique approach enables the creation of agonist and multifunctional antibodies, which have historically been challenging to design using only structural data. Leveraging its core strengths in molecular optimization speed and efficient design capabilities, Metaphore is currently advancing a pipeline comprising multiple programs, focusing on disease areas with high unmet medical needs, aiming to develop the next generation of antibody therapeutics.